ALR Technologies Announces Completion of Pivotal Non-Inferiority Study on the GluCurve Pet CGM

Stock Information for ALR Technologies, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ALR Technologies, Inc.

ALR Technologies Announces Sales Guidance for Q4 2022, Q1 2023, and Completion of the GluCurve Pet CGM Manufacturing Agreement
ALR Technologies Announces Update to Singapore Migration Merger and GluCurve Pet CGM Commercialization
ALR Technologies Announces Update on the GluCurve Pet CGM Distribution and Commercialization
ALR Technologies Announces First Shipment of GluCurve Pet CGMs Expected in October and Update on the Manufacturing Agreement
ALR Technologies Completes Definitive Manufacturing Agreement with Infinovo Medical for the GluCurve Pet CGM Hardware
ALR Technologies Announces Reincorporation Merger
ALR Technologies Announces Successful Preliminary Results for the GluCurve Pet CGM Non-Inferiority Study
ALR Technologies Announces Completion of Continuous Glucose Monitor (CGM) Integration and Provides Update on Human Initiatives

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.